Awesome Chemistry Experiments For (2R,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane

If you are interested in 98760-08-8, you can contact me at any time and look forward to more communication. Application In Synthesis of (2R,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane.

In an article, author is Karanewsky, Donald S., once mentioned the application of 98760-08-8, Application In Synthesis of (2R,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane, Name is (2R,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane, molecular formula is C15H21NO3, molecular weight is 263.3321, MDL number is MFCD00671705, category is dioxoles. Now introduce a scientific discovery about this category.

Toxicological evaluation and metabolism of two N-alkyl benzamide umami flavour compounds: N-(heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide and (R)-N-(1-methoxy-4-methylpentan-2-y1)-3,4-dimethylbenzamide

Toxicological evaluations of two N-alkyl benzamide umami flavour compounds, N-(heptan-4-yl) benzo[d][1,3]dioxole-5-carboxamide (S807, CAS 745047-51-2) and (R)-N-(1-methoxy-4-methylpentan2-y1)-3,4-dimethylbenzamide (S9229, CAS 851669-60-8), were completed for the purpose of assessing their safety for use in food and beverage applications. Both 5807 and 59229 undergo rapid oxidative metabolism by both rat and human liver microsomes in vitro. In pharmacokinetic studies in rats, the systemic exposure to 59229 on oral administration is very low at all doses (% F < 1%), while that of 5807 demonstrated a non-linear dose dependence. In metabolism studies in rats, hydroxylation of the C-4 aryl methyl group was found to be the dominant metabolic pathway for 59229. The dominant metabolic pathway for 5807 in the rat involved oxidative scission of the methylenedioxy moiety to produce the corresponding 3,4-dihydroxybenamide which is further converted by Phase II metabolic enzymes to the 3- and 4-0-methyl ethers as well as their corresponding glucuronides. Both 5807 and 59229 were not found to be mutagenic or clastogenic in vitro, and did not induce micronuclei in polychromatic erythrocytes in vivo. In a subchronic oral toxicity study in rats, the no-observed-effect-level (NOEL) for 5807 was 20 mg/kg bw/day when administered in the diet for 13 weeks. The no-observed-adverse-effect-level (NOAEL) for 59229 in rats was 100 mg/kg bw/day (highest dose tested) when administered in the diet for 28 consecutive days. (C) 2016 Published by Elsevier Ireland Ltd. If you are interested in 98760-08-8, you can contact me at any time and look forward to more communication. Application In Synthesis of (2R,3S)-1,2-Epoxy-3-(Boc-amino)-4-phenylbutane.

Reference:
1,3-Benzodioxole – Wikipedia,
,Dioxole | C3H4O2 – PubChem